| # | Side effect | Count |
|---|---|---|
| 0 | OVARIAN HYPERSTIMULATION SYNDROME | 640 |
| 1 | NO ADVERSE EVENT | 227 |
| 2 | PRODUCT DOSE OMISSION ISSUE | 139 |
| 3 | DRUG INEFFECTIVE | 125 |
| 4 | ABDOMINAL DISTENSION | 113 |
| 5 | PRODUCT PACKAGING QUANTITY ISSUE | 103 |
| 6 | NAUSEA | 100 |
| 7 | OFF LABEL USE | 96 |
| 8 | PRODUCT QUALITY ISSUE | 96 |
| 9 | ASCITES | 92 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN CHORIONIC GONADOTROPIN NEGATIVE | 6 | 0.2857 |
| 1 | OVARIAN HYPERSTIMULATION SYNDROME | 640 | 0.2743 |
| 2 | OVARIAN HAEMORRHAGE | 25 | 0.1055 |
| 3 | FAILED IN VITRO FERTILISATION | 5 | 0.0820 |
| 4 | MULTIPLE PREGNANCY | 12 | 0.0670 |
| 5 | OVARIAN ENLARGEMENT | 23 | 0.0599 |
| 6 | HUMAN CHORIONIC GONADOTROPIN DECREASED | 5 | 0.0450 |
| 7 | ADNEXAL TORSION | 12 | 0.0379 |
| 8 | ANOVULATORY CYCLE | 7 | 0.0338 |
| 9 | OVARIAN ABSCESS | 5 | 0.0321 |